227 related articles for article (PubMed ID: 24056641)
1. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
2. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors for Breast Cancer: an Immunomorphological Update.
Roncati L; Barbolini G; Piacentini F; Piscioli F; Pusiol T; Maiorana A
Pathol Oncol Res; 2016 Jul; 22(3):449-52. PubMed ID: 26589512
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB
Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of T lymphocytes infiltration in breast cancer].
Yu HM; Jiao SC; Yang JL; Wang JD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
Oldford SA; Robb JD; Watson PH; Drover S
Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
[TBL] [Abstract][Full Text] [Related]
14. Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.
Loughlin PM; Cooke TG; George WD; Gray AJ; Stott DI; Going JJ
J Immunol Methods; 2007 Apr; 321(1-2):32-40. PubMed ID: 17324439
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
[TBL] [Abstract][Full Text] [Related]
16. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
Matkowski R; Gisterek I; Halon A; Lacko A; Szewczyk K; Staszek U; Pudelko M; Szynglarewicz B; Szelachowska J; Zolnierek A; Kornafel J
Anticancer Res; 2009 Jul; 29(7):2445-51. PubMed ID: 19596912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N
BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917
[TBL] [Abstract][Full Text] [Related]
20. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
